Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Prothena Corporation PLC (NASDAQ:PRTA)

40.10
Delayed Data
As of 4:00pm ET
 +0.15 / +0.38%
Today’s Change
34.85
Today|||52-Week Range
70.00
+6.96%
Year-to-Date

Today’s Trading

Previous close39.95
Today’s open40.49
Day’s range39.35 - 40.97
Volume528,804
Average volume (3 months)327,248
Market cap$1.5B
Data as of 4:00pm ET, 01/17/2018

Growth & Valuation

Earnings growth (last year)-75.19%
Earnings growth (this year)+8.86%
Earnings growth (next 5 years)-16.37%
Revenue growth (last year)-34.35%
P/E ratioNM
Price/Sales1,601.64
Price/Book3.80

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...+3.75+8.77%
HZNPHorizon Pharma PLC+0.37+2.53%
AXONAxovant Sciences Ltd-0.04-1.90%
FOLDAmicus Therapeutics ...+0.71+4.71%
Data as of 4:15pm ET, 01/17/2018

Financials

Next reporting dateMarch 8, 2018
EPS forecast (this quarter)-$1.46
Annual revenue (last year)$1.1M
Annual profit (last year)-$160.1M
Net profit margin-15,176.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gene G. Kinney
Chief Financial Officer
Tran B. Nguyen
Corporate headquarters
Dun Laoghaire, Dublin

Forecasts